Clinical Trial Update: Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer [NA]

View source ↗

Summary

A new clinical trial is evaluating a liquid biopsy-based modality for postoperative management of non-small cell lung cancer and is currently recruiting at Peki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Peking University People's Hospital | Conditions: Non-small Cell Lung Cancer, Minimal Residual Disease | NA | Status: RECRUITING